| Mepha Pharma AG - Olanzapin-Mepha Teva oro 5 mg, Schmelztabletten |
| 58624 | | 07 | | Olanzapin-Mepha Teva oro 5 mg | | Schmelztabletten | | N05AH03 | | Olanzapine | | 03.02.2012 | | |
|
| Composition |
| olanzapinum 5 mg, mannitolum 69 mg, magnesii stearas, crospovidonum, lactosum monohydricum 50 mg, hydroxypropylcellulosum substitutum humile, aromatica (Zitrone) cum saccharum 0.264 mg et aspartamum 2.25 mg, pro compresso. |
| Packungsbestandteile |
| Melting tablets | | | | Active Agent | Dose |
|---|
| Olanzapine | 5 mg |
| | | | Inactive agents | Dose |
|---|
| Aromatica (Zitrone) cum Saccharum | 0.264 mg | | Aspartame | 2.25 mg | | Crospovidonum | | | Hydroxypropylcellulosum Substitutum Humile | | | Lactose Monohydrate | 50 mg | | Magnesii Stearas | | | Mannitol | 69 mg | | Pro Compresso | |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 012 | 30 | PR | PR | B | | No | | 013 | 100 | PR | PR | B | | No |
|
